Tell us about your current research project...Â
My research is aimed at using the latest techniques of MRI imaging to understand the progression of MS and be able to predict how the disease will progress. I will use this as a biomarker to measure the efficacy of drug treatments, such as remyelination drugs.. Specifically I will be using Diffusion Weighted Imaging (DWI) alongside traditional imaging techniques, such as T1 and FLAIR, to track the evolution of lesions and other pathological structures such as the Choroid Plexus. This will allow me to measure and evaluate slow-burning inflammation at the rim of chronic MS lesions; and, as such, this can be used as a biomarker of chronic slow-burning inflammation and associated progressive brain tissue damage.